US Patent 7632501 Antibodies against monocyte chemotactic proteins
Patent 7632501 was granted and assigned to Biogen on December, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Antonin R. De Fougerolles0
Carl Reid0
Ellen Garber0
Victor E. Kotelianski0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+259 characters)
Article
Patent abstract
The invention provides antibodies that bind to a plurality of β-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07632501 Antibodies against monocyte chemotactic proteins US Patent 7632501 Antibodies against monocyte chemotactic proteins
Infobox
Patent Number
076325010
Patent Number
76325010
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076325010
Date of Patent
December 15, 2009
0Patent Application Number
121717910
Date Filed
July 11, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07632501 Antibodies against monocyte chemotactic proteins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07632501
Date of patent
December 15, 2009
Patent application number
12171791
Date Filed
July 11, 2008
Patent primary examiner
Find more entities like US Patent 7632501 Antibodies against monocyte chemotactic proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.